English
Regional settings| Spread | 0.05 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ US$5,000.00 Short position overnight fee ~ US$4,000.00 | -0.026179% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ US$5,000.00 Short position overnight fee ~ US$4,000.00 | 0.003957% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | USD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | United States of America | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 0.82 |
| Open | 0.77 |
| 1-Year Change | -38.4% |
| Day's Range | 0.72 - 0.79 |
Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug deoxyribonucleic acid (DNA) code in engineered organisms to execute programs for its customers. Its platform is used by customers for manufacturing processes or develop new products through biology. The foundation of its platform includes two assets that execute a variety of cell programs for customers according to their specifications: Foundry and Codebase. It serves industries, including chemicals, agriculture, food, consumer products and pharmaceuticals.
BRIEF: For the nine months ended 30 September 2021, Ginkgo Bioworks Holdings Inc revenues totaled $165.3M. Net loss totaled to $229.4M.
